THIVISA RAJAGOPAL

Allopathic & Osteopathic Physicians|Family Medicine CANTON, NY NPI 1659723005

General Payments — all program years on this page

$2,075.83

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 85
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $853.18 across 37 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $841.6236
Education $11.561

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $288.0211
Novo Nordisk AS $282.8112
Lilly USA, LLC $64.833
Gilead Sciences, Inc. $54.913
Amgen Inc. $43.132
Exact Sciences Corporation $41.122
Daiichi Sankyo Inc. $24.051
DEXCOM, INC. $23.541
GlaxoSmithKline, LLC. $17.701
Indivior Inc. $13.071

By program year

Program yearAmountRecords
2018 $50.521
2020 $17.391
2022 $334.0813
2023 $820.6633
2024 $853.1837

Records — PY2024 (37)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089472023 Daiichi Sankyo Inc. $24.05 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096640191 Novo Nordisk Inc $18.00 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096677771 Novo Nordisk Inc $16.28 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096910643 Novo Nordisk Inc $17.00 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096924146 Novo Nordisk Inc $23.72 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096956467 Novo Nordisk Inc $18.17 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096982549 Novo Nordisk Inc $17.00 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097231876 Novo Nordisk Inc $22.61 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097330234 Novo Nordisk Inc $73.09 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097367339 Novo Nordisk Inc $20.45 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097380241 Novo Nordisk Inc $21.17 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097647395 Novo Nordisk Inc $13.24 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097738335 Novo Nordisk Inc $22.08 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104320654 AstraZeneca Pharmaceuticals LP $16.20 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104464014 AstraZeneca Pharmaceuticals LP $13.91 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104520762 AstraZeneca Pharmaceuticals LP $111.40 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104561370 AstraZeneca Pharmaceuticals LP $15.22 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104686166 AstraZeneca Pharmaceuticals LP $17.11 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104756722 AstraZeneca Pharmaceuticals LP $30.85 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105573915 AstraZeneca Pharmaceuticals LP $23.28 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105598433 AstraZeneca Pharmaceuticals LP $20.53 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105634546 AstraZeneca Pharmaceuticals LP $13.20 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105692291 AstraZeneca Pharmaceuticals LP $11.56 08/22/2024 Education Undisputed 01/23/2026 View at CMS
1105737005 AstraZeneca Pharmaceuticals LP $14.76 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114845712 Exact Sciences Corporation $19.51 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114845717 Exact Sciences Corporation $21.61 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116128492 GlaxoSmithKline, LLC. $17.70 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117661525 Amgen Inc. $26.04 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117661527 Amgen Inc. $17.09 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133739422 Gilead Sciences, Inc. $17.63 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133739424 Gilead Sciences, Inc. $16.70 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133739426 Gilead Sciences, Inc. $20.58 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135463186 Lilly USA, LLC $16.91 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135463188 Lilly USA, LLC $23.96 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135491730 Lilly USA, LLC $23.96 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144536085 Indivior Inc. $13.07 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153340407 Dexcom, Inc. $23.54 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.